Canada
# |
Name |
Revenue |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 175.51 M
|
Dec. 31, 2023 | USD 7.95 | -0.62% |
|
Canada |
|
2 |
USD 81.76 M
|
Nov. 30, 2023 | USD 1.52 | 2.02% |
|
Canada |
|
3 |
USD 38.02 M
|
Dec. 31, 2023 | USD 3.17 | -1.86% |
|
Canada |
|
4 |
USD 907.66 K
|
Dec. 31, 2023 | USD 0.15 | -5.56% |
|
Canada |
|
5 |
USD 0.00
|
March 31, 2024 | USD 0.85 | -3.04% |
|
Canada |
|
6 |
USD 0.00
|
Sept. 30, 2024 | USD 1.91 | 1.06% |
|
Canada |
|
7 |
USD 0.00
|
Dec. 31, 2023 | USD 0.73 | 3.09% |
|
Canada |
|
8 |
USD 0.00
|
Dec. 31, 2023 | USD 1.45 | 3.65% |
|
Canada |
|
9 |
USD 0.00
|
Dec. 31, 2023 | USD 0.89 | -2.92% |
|
Canada |
|
10 |
USD 0.00
|
June 30, 2024 | NA |
|
Canada |
The Vaccines company in Canada with the highest Revenue is Aurinia Pharmaceuticals Inc. (NasdaqGM: AUPH) at USD 175.51 M.
The Vaccines company in Canada with the lowest Revenue is Defence Therapeutics Inc. (Canadian Sec Stock Exchange: DTC.CN) at USD 0.00.
The top 10 Vaccines companies in Canada by Revenue are Aurinia Pharmaceuticals Inc., Theratechnologies Inc., AbCellera Biologics Inc., Ondine Biomedical Inc., Medicenna Therapeutics Corp., Edesa Biotech, Inc., Oncolytics Biotech Inc., Cardiol Therapeutics Inc., XORTX Therapeutics Inc. and Defence Therapeutics Inc..
The bottom 10 Vaccines companies in Canada by Revenue are Defence Therapeutics Inc., XORTX Therapeutics Inc., Cardiol Therapeutics Inc., Oncolytics Biotech Inc., Edesa Biotech, Inc., Medicenna Therapeutics Corp., Ondine Biomedical Inc., AbCellera Biologics Inc., Theratechnologies Inc. and Aurinia Pharmaceuticals Inc..